UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma

Annals of oncology, 2018-03, Vol.29 (3), p.700-706

2018

Volltextzugriff (PDF)

Advancement in the routine identification of anaerobic bacteria by MALDI-TOF mass spectrometry

European journal of clinical microbiology & infectious diseases, 2013-09, Vol.32 (9), p.1183-1192

2013

Volltextzugriff (PDF)

Alternative splicing: good and bad effects of translationally silent substitutions

The FEBS journal, 2010-02, Vol.277 (4), p.836-840

2010

Volltextzugriff (PDF)

Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma

Annals of oncology, 2018-10, Vol.29 (10), p.2143-2143

2018

Volltextzugriff (PDF)

Medical conditions of children and young people with Down syndrome

Journal of intellectual disability research, 2021-02, Vol.65 (2), p.199-209

2021

Volltextzugriff (PDF)

Incidence and risk factors of bacterial sepsis and invasive fungal infection in neonates and infants requiring major surgery: an Italian multicentre prospective study

The Journal of hospital infection, 2022-12, Vol.130, p.122-130

2022

Volltextzugriff (PDF)

Human NDE1 splicing and mammalian brain development

Scientific reports, 2017-03, Vol.7 (1), p.43504-43504, Article 43504

2017

Volltextzugriff (PDF)

Acute toxic exposures in children: analysis of a three year registry managed by a Pediatric poison control Center in Italy

Italian journal of pediatrics, 2021-06, Vol.47 (1), p.1-125, Article 125

2021

Volltextzugriff (PDF)

A phase III, double-blind, randomized study of pamiparib versus placebo as maintenance therapy in patients with inoperable, locally advanced, or metastatic gastric cancer that responded to platinum-based first-line chemotherapy

Annals of oncology, 2018-10, Vol.29, p.viii265-viii265

2018

Volltextzugriff (PDF)

A phase 3, double-blind, randomized study of pamiparib versus placebo as maintenance therapy in patients with inoperable, locally advanced, or metastatic gastric cancer that responded to platinum-based first-line chemotherapy - Trial in progress

Annals of oncology, 2018-06, Vol.29, p.v25-v26

2018

Volltextzugriff (PDF)

Nitrous oxide occupational exposure in conscious sedation procedures in dental ambulatories: a pilot retrospective observational study in an Italian pediatric hospital

BMC anesthesiology, 2019-03, Vol.19 (1), p.42-9, Article 42

2019

Volltextzugriff (PDF)

Validity of Non-Invasive Fibrosis Scores in a Large Cohort of Paediatric NAFLD

Journal of hepatology, 2016, Vol.64 (2), p.S300-S300

2016

Volltextzugriff (PDF)

Rociletinib in EGFR-Mutated Non–Small-Cell Lung Cancer

The New England journal of medicine, 2015-04, Vol.372 (18), p.1700-1709

2015

Volltextzugriff (PDF)

AEROSOL CLASSIFICATION FOR TUCUMÁN AERONET STATION, ARGENTINA

Anales AFA, 2020-07, Vol.31 (2), p.39-45

2020

Volltextzugriff (PDF)

Feasibility of monitoring response to the PARP inhibitor rucaparib with targeted deep sequencing of circulating tumor DNA (ctDNA) in women with high grade ovarian carcinoma on the ARIEL2 trial

European journal of cancer (1990), 2016-12, Vol.69, p.S123-S123

2016

Volltextzugriff (PDF)

Strategies to control antibiotic resistance: results from a survey in Italian children's hospitals

Annali di igiene, 2019-01, Vol.31 (1), p.3-12

2019

Volltextzugriff (PDF)

Secondary mutations in RAD51C and RAD51D are associated with acquired resistance to the PARP inhibitor rucaparib in patients with high-grade ovarian cancer

European journal of cancer (1990), 2016-12, Vol.69, p.S13-S13

2016

Volltextzugriff (PDF)

Comparison of clinical features and outcomes in COVID-19 and influenza pneumonia patients requiring intensive care unit admission

Infection, 2021-10, Vol.49 (5), p.965-975

2021

Volltextzugriff (PDF)

Functional splicing assay shows a pathogenic intronic mutation in neurofibromatosis type 1 (NF1) due to intronic sequence exonization

Human mutation, 2006-03, Vol.27 (3), p.294-295

2006

Volltextzugriff (PDF)

2700 Final results of ARIEL2 (Part 1): A phase 2 trial to prospectively identify ovarian cancer (OC) responders to rucaparib using tumor genetic analysis

European journal of cancer (1990), 2015-09, Vol.51, p.S531-S531

2015

Volltextzugriff (PDF)

2701 Quantification of genomic loss of heterozygosity enables prospective selection of ovarian cancer patients who may derive benefit from the PARP inhibitor rucaparib

European journal of cancer (1990), 2015-09, Vol.51, p.S531-S532

2015

Volltextzugriff (PDF)

Troponin I and B-type Natriuretic Peptide (BNP) as biomarkers for the prediction of cardiotoxicity in patients with breast cancer treated with adjuvant anthracyclines and trastuzumab

Clinica terapeutica, 2015, Vol.166 (1), p.e67

2015

Volltextzugriff (PDF)

Incidence of surgical site infections in children: active surveillance in an Italian academic children's hospital

Annali di igiene, 2017-01, Vol.29 (1), p.46-53

2017

Volltextzugriff (PDF)

215 Updated clinical and preliminary correlative results of ARIEL2, a Phase 2 study to identify ovarian cancer patients likely to respond to rucaparib

European journal of cancer (1990), 2014-11, Vol.50, p.73-73

2014

Volltextzugriff (PDF)

Point prevalence study of antibiotic use in a paediatric hospital in Italy

Euro surveillance : bulletin européen sur les maladies transmissibles, 2008-10, Vol.13 (41)

2008

Volltextzugriff (PDF)

1 – 25 von 359

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(324)
Mit Volltextzugriff
(277)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma

Advancement in the routine identification of anaerobic bacteria by MALDI-TOF mass spectrometry

Alternative splicing: good and bad effects of translationally silent substitutions

Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma

Medical conditions of children and young people with Down syndrome

Incidence and risk factors of bacterial sepsis and invasive fungal infection in neonates and infants requiring major surgery: an Italian multicentre prospective study

Human NDE1 splicing and mammalian brain development

Acute toxic exposures in children: analysis of a three year registry managed by a Pediatric poison control Center in Italy

A phase III, double-blind, randomized study of pamiparib versus placebo as maintenance therapy in patients with inoperable, locally advanced, or metastatic gastric cancer that responded to platinum-based first-line chemotherapy

A phase 3, double-blind, randomized study of pamiparib versus placebo as maintenance therapy in patients with inoperable, locally advanced, or metastatic gastric cancer that responded to platinum-based first-line chemotherapy - Trial in progress

Nitrous oxide occupational exposure in conscious sedation procedures in dental ambulatories: a pilot retrospective observational study in an Italian pediatric hospital

Validity of Non-Invasive Fibrosis Scores in a Large Cohort of Paediatric NAFLD

Rociletinib in EGFR-Mutated Non–Small-Cell Lung Cancer

AEROSOL CLASSIFICATION FOR TUCUMÁN AERONET STATION, ARGENTINA

Feasibility of monitoring response to the PARP inhibitor rucaparib with targeted deep sequencing of circulating tumor DNA (ctDNA) in women with high grade ovarian carcinoma on the ARIEL2 trial

Strategies to control antibiotic resistance: results from a survey in Italian children's hospitals

Secondary mutations in RAD51C and RAD51D are associated with acquired resistance to the PARP inhibitor rucaparib in patients with high-grade ovarian cancer

Comparison of clinical features and outcomes in COVID-19 and influenza pneumonia patients requiring intensive care unit admission

Functional splicing assay shows a pathogenic intronic mutation in neurofibromatosis type 1 (NF1) due to intronic sequence exonization

2700 Final results of ARIEL2 (Part 1): A phase 2 trial to prospectively identify ovarian cancer (OC) responders to rucaparib using tumor genetic analysis

2701 Quantification of genomic loss of heterozygosity enables prospective selection of ovarian cancer patients who may derive benefit from the PARP inhibitor rucaparib

Troponin I and B-type Natriuretic Peptide (BNP) as biomarkers for the prediction of cardiotoxicity in patients with breast cancer treated with adjuvant anthracyclines and trastuzumab

Incidence of surgical site infections in children: active surveillance in an Italian academic children's hospital

215 Updated clinical and preliminary correlative results of ARIEL2, a Phase 2 study to identify ovarian cancer patients likely to respond to rucaparib

Point prevalence study of antibiotic use in a paediatric hospital in Italy

Suchergebnisse filtern